Mary Hedley Net Worth

The estimated Net Worth of Mary Lynne Hedley is at least $1.47 Milhão dollars as of 1 September 2024. Mary Hedley owns over 343 units of Veeva Systems Inc stock worth over $1,136,293 and over the last 8 years he sold VEEV stock worth over $146,381. In addition, he makes $187,393 as Independent Director at Veeva Systems Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mary Hedley VEEV stock SEC Form 4 insiders trading

Mary has made over 29 trades of the Veeva Systems Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 343 units of VEEV stock worth $76,798 on 1 September 2024.

The largest trade he's ever made was exercising 23,390 units of Veeva Systems Inc stock on 20 December 2018 worth over $154,842. On average, Mary trades about 749 units every 39 days since 2017. As of 1 September 2024 he still owns at least 5,075 units of Veeva Systems Inc stock.

You can see the complete history of Mary Hedley stock trades at the bottom of the page.

Mary Hedley biography

Dr. Mary Lynne Hedley Ph.D. serves as Independent Director of the Company. Dr. Hedley serves as President and Chief Operating Officer of TESARO, an oncology-focused pharmaceutical company acquired by GlaxoSmithKline plc in January 2019. Dr. Hedley previously served as president of TESARO since co-founding the company in March 2010 prior to its acquisition by GlaxoSmithKline. From July 2009 to February 2010, Dr. Hedley served as Executive Vice President of Operations and Chief Scientific Officer of Abraxis BioScience, Inc., a biotechnology company. Dr. Hedley served as Executive Vice President of Eisai Corporation of North America from January 2008 until July 2009, following Eisai Co. Ltd.’s acquisition of MGI PHARMA, Inc. in January 2008. Dr. Hedley also served in various positions at MGI PHARMA, Inc. from 2004 through its acquisition in 2008, most recently as Executive Vice President and Chief Scientific Officer. Prior to that, Dr. Hedley co-founded and served as the President and Chief Executive Officer of ZYCOS, Inc., a biotechnology company, which was acquired by MGI PHARMA, Inc., in 2004. Dr. Hedley completed two consecutive postdoctoral fellowships at Harvard University and received a Bachelor of Science degree in Microbiology from Purdue University and a Doctor of Philosophy degree in Immunology from the University of Texas, Southwestern Medical Center.

What is the salary of Mary Hedley?

As the Independent Director of Veeva Systems Inc, the total compensation of Mary Hedley at Veeva Systems Inc is $187,393. There are 16 executives at Veeva Systems Inc getting paid more, with Thomas Schwenger having the highest compensation of $8,090,590.

How old is Mary Hedley?

Mary Hedley is 57, he's been the Independent Director of Veeva Systems Inc since 2019. There are 6 older and 15 younger executives at Veeva Systems Inc. The oldest executive at Veeva Systems Inc is Timothy Barabe, 67, who is the Independent Director.

What's Mary Hedley's mailing address?

Mary's mailing address filed with the SEC is Eli Lilly and Company Corporate Center, Indianapolis, Marion County, Indiana, United States.

Insiders trading at Veeva Systems Inc

Over the last 11 years, insiders at Veeva Systems Inc have traded over $2,373,995,980 worth of Veeva Systems Inc stock. The most active insiders traders include Gordon Ritter, Capital Partners Ii Lpemerg..., eKevin Spain. On average, Veeva Systems Inc executives and independent directors trade stock every 3 days with the average trade being worth of $12,654,156. The most recent stock trade was executed by Timothy S Cabral on 1 September 2024, trading 315 units of VEEV stock currently worth $70,529.

What does Veeva Systems Inc do?

veeva systems inc. is a leader in cloud-based software for the global life sciences industry. committed to innovation, product excellence, and customer success, veeva has more than 300 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. veeva is headquartered in the san francisco bay area, with offices in europe, asia, and latin america. for more information, visit www.veeva.com.

Complete history of Mary Hedley stock trades at Bluebird bio Inc, Lilly(Eli) & Co, Veeva Systems Inc, eMillendo Therapeutics

Veeva Systems Inc executives and stock owners

Veeva Systems Inc executives and other stock owners filed with the SEC include:

• Thomas Schwenger,
  President, Chief Operating Officer
• Alan Mateo,
  Executive Vice President of Global Sales
• E. Nitsa Zuppas,
  Chief Marketing Officer
• Frederic Lequient,
  Sr. VP of Global Customer Services
• Alan V. Mateo,
  Exec. VP of Global Sales
• Eleni Nitsa Zuppas,
  Chief Marketing Officer
• Peter P. Gassner,
  Founder, CEO & Director
• Peter Gassner,
  Chief Executive Officer, Director
• Gordon Ritter,
  Independent Chairman of the Board
• Frederic Lequient,
  Senior Vice President - Global Customer Services
• Jonathan Faddis,
  Senior Vice President, General Counsel, Corporate Secretary
• Ronald Codd,
  Independent Director
• Timothy Barabe,
  Independent Director
• Paul Chamberlain,
  Independent Director
• Mark Carges,
  Independent Director
• Paul Sekhri,
  Independent Director
• Mary Hedley,
  Independent Director
• Matthew Wallach,
  Director
• Rick Lund,
  Investor Relations Director
• Brent Bowman,
  Chief Financial Officer
• Jonathan W. Faddis,
  Sr. VP, Gen. Counsel & Corp. Sec.
• Ato Garrett,
  Sr. Director of Investor Relations
• Catherine Allshouse,
  Global Chief Information Officer & Head of Operations
• Michele O'Connor,
  Chief Accounting Officer
• Thomas D. Schwenger,
  Pres & COO
• Frank Defesche,
  SVP, Global Customer Services
• Mark Armenante,
  Director
• Young A Sohn,
  Director
• Capital Partners Ii Lpemerg...,
  
• Kevin Spain,
  Director
• Jenna Mitchell,
  10% owner
• Maja Kristin,
  10% owner
• James Burr Ramsey,
  10% owner
• Craig Ramsey,
  10% owner
• Michele O'connor,
  Chief Accounting Officer
• Nimrata Hunt,
  Director
• Marshall Mohr,
  Director
• Priscilla Hung,
  Director
• Kristine Diamond,
  Chief Accounting Officer
• Stacey Epstein,
  Chief Marketing Officer
• Timothy S Cabral,
  Interim CFO